ACS Synthetic BiologySynthetic BiologyPeer-reviewed journal article
Reconstitution of human cytochrome P450 activity using a Leishmania cell-free protein expression system
Wayne A. JohnstoniD, Raine E. S. ThomsoniD, Juan Alfaro-Palma, Robert E. SpeightiD, Kirill A. AlexandroviD, Elizabeth M. J. GillamiD, James B. Y. H. BehrendorffiD
- Citations
- 2
- FWCI
- 1.93
- Field percentile
- top 15%
Abstract
Cytochrome P450 enzymes (P450s) are ubiquitous in drug metabolism and natural product biosynthesis. Studying eukaryotic P450s has been limited by their dependence on membrane association and requirement for partner reductases. Here, we demonstrate cell-free synthesis and assay of human P450s 3A4 and 2D6 using Leishmania tarentolae translational extract. These P450s were co-expressed with various NADPH-cytochrome P450 reductases (CPRs), and activity was assayed directly using unpurified reactions. P450s 3A4 and 2D6 showed distinct preferences in reductase coupling: P450 3A4 activity was greatest when coupled to the human CPR, whereas P450 2D6 performed better when co-expressed with CPRs from Arabidopsis thaliana. Inhibition assays with chloramphenicol, terbinafine, and erythromycin yielded results consistent with known P450-drug interactions. We conclude that Leishmania-based cell-free protein synthesis resolves previous challenges in eukaryotic P450 expression, allowing for rapid and convenient functional studies of unmodified eukaryotic P450 systems, offering a practical tool for drug metabolism studies and biocatalyst discovery.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of active mouse, plant and fungal cytochrome P450s in endogenous proteomes and upon expression in planta.
M. Font Farre, D. Brown, … R. A. L. van der Hoorn·bioRxiv·Mar 18, 2024
- Systematic engineering of plant cytochrome P450 system identifies a comprehensive strategy for expression of highly functional P450 enzymes in Escherichia coli
M. Poborsky, C. Crocoll, … B. A. Halkier·bioRxiv·Dec 13, 2022
- Across kingdom biased CYP-mediated metabolism via small-molecule ligands docking on P450 oxidoreductase
S. B. Jensen, S. Thodberg, … N. S. Hatzakis·bioRxiv·Sep 23, 2020
- Loss of multiple enzyme activities due to the human genetic variation P284T in NADPH cytochrome P450 oxidoreductase
S. Parween, M. N. R. Velazquez, … A. V. Pandey·bioRxiv·May 20, 2019
- Variability in Human Drug Metabolizing Cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 Activities Caused by Genetic Variations in Cytochrome P450 Oxidoreductase
M. N. R. Velazques, S. Parween, … A. V. Pandey·bioRxiv·May 17, 2019
- An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase
G. Mukherjee, P. P. Nandekar, R. C. Wade·bioRxiv·Jun 12, 2020